Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Clinical Trial of Ambrisentan and Tadalafil in Pulmonary Arterial Hypertension Associated With Systemic Sclerosis

NCT01042158 is registered in ClinicalTrials.gov with Johns Hopkins University as lead sponsor.

NCT NCT01042158
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01042158 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Clinical Trial of Ambrisentan and Tadalafil in Pulmonary Arterial Hypertension Associated With Systemic Sclerosis
Lead sponsor
Johns Hopkins University
Phase
Phase 4
Overall status
Completed
Start date
January 31, 2010
Completion date
November 30, 2014
Enrollment
25 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

connective tissue disease, pulmonary arterial hypertension, pulmonary hypertension, scleroderma spectrum of diseases, systemic sclerosis